Postdoctoral Position in Health Sciences (University of Antwerp)

Department: Molecular - Morphology - Microscopy Regime: Full-time Institution: University of Antwerp About the University of Antwerp The University of Antwerp is a dynamic, forward-thinking university. We offer an innovative academic education to more than 20,000 students, conduct pioneering scientific research, and play an important service-providing role in society. We are one of the largest, most international, and most innovative employers in the region. With more than 6,000 employees from 100 different countries, we help build tomorrow's world every day. Through top scientific research, we push back boundaries and set a course for the future – a future that you can help to shape. Position Overview The Center for Radiopharmaceuticals Antwerp (CREANT), part of Molecular Imaging and Radiology (MIRA) in the Faculty of Medicine & Health Sciences, is looking for a full-time (100%) Postdoctoral Scholarship Holder in the field of preclinical radioligand development for theranostic applications. You will conduct research within the Radiopharmacy (CREANT) department and the Molecular Imaging Center Antwerp (MICA), focusing on the preclinical evaluation of theranostic radioligands targeting tumor-associated proteases. Project Overview: CREANT has expertise in the development of radiolabeled ligands for proteases implicated in human diseases, applicable in PET, SPECT, and targeted radionuclide therapy. The team has developed novel FAP-targeted radioligands (FAPIs) with improved tumor retention and pharmacokinetics. This project aims to conjugate these ligands with alpha-emitting radionuclides for precise tumor tissue destruction while sparing healthy organs. The ultimate goal is to generate preclinical data to support translation into a Phase I clinical trial. Role and Responsibilities The successful candidate will: Design, plan, and execute preclinical experiments in cell and animal cancer models. Conduct biodistribution, dosimetry, and therapeutic efficacy studies of radiolabeled-FAPI conjugates. Perform molecular and histological analyses of treatment effects on the tumor microenvironment. Collaborate with radiochemistry, imaging, and oncology teams within the consortium. Contribute to scientific publications, reports, and international conference presentations. Profile / Requirements Doctoral degree (PhD) in oncology, cancer biology, pharmacology, radiobiology, radiopharmacy, pharmaceutical sciences, or a related field from a non-Belgian institution. Strong expertise in preclinical animal models (rodents), tumor biology, and therapeutic testing. Hands-on experience with cell culture and in vitro assays. Experience in small animal imaging and radiopharmaceuticals is a plus. Ability to work independently and collaboratively in a multidisciplinary environment. Excellent scientific writing and communication skills in English. Research qualities aligned with faculty and university research policies. Act with attention to quality, integrity, creativity, and cooperation. What We Offer Opportunity to contribute to cutting-edge translational cancer research with direct clinical impact. Collaborative and supportive environment within a multidisciplinary consortium. Access to state-of-the-art preclinical imaging and radiochemistry facilities. Opportunities for career development, mentoring, and international networking. Full-time postdoctoral scholarship for 1 year, extendable up to 3 years after positive evaluation. Planned start date: March 2, 2026 (or as soon as possible thereafter). Monthly scholarship amount according to postdoctoral scholarship scales for Contract Research Staff (BAP). Ecocheques, bicycle allowance, or reimbursement of public transport costs for commuting. Work location: Laboratories of Radiopharmacy and MICA at campus Drie Eiken, University of Antwerp. How to Apply Apply through the University of Antwerp online job application platform. Include: Motivation letter Academic CV Names and contact details of at least two referees Applications will be reviewed on a rolling basis until the position is filled. Questions: Online application form: jobs@uantwerpen.be Job content: Prof. Filipe Elvas – filipe.elvas@uantwerpen.be Diversity and Inclusion The University of Antwerp has received the European Commission’s HR Excellence in Research Award. We are a sustainable, family-friendly organization that invests in employee growth. We encourage diversity and value an inclusive working environment and equal opportunities, regardless of gender identity, disability, race, ethnicity, religion or belief, sexual orientation, or age. We encourage people from diverse backgrounds and with diverse characteristics to apply. If you apply for this position please say you saw it on Academicoxy

Department: Molecular - Morphology - Microscopy
Regime: Full-time
Institution: University of Antwerp

About the University of Antwerp

The University of Antwerp is a dynamic, forward-thinking university. We offer an innovative academic education to more than 20,000 students, conduct pioneering scientific research, and play an important service-providing role in society. We are one of the largest, most international, and most innovative employers in the region. With more than 6,000 employees from 100 different countries, we help build tomorrow's world every day. Through top scientific research, we push back boundaries and set a course for the future – a future that you can help to shape.

Position Overview

The Center for Radiopharmaceuticals Antwerp (CREANT), part of Molecular Imaging and Radiology (MIRA) in the Faculty of Medicine & Health Sciences, is looking for a full-time (100%) Postdoctoral Scholarship Holder in the field of preclinical radioligand development for theranostic applications.

You will conduct research within the Radiopharmacy (CREANT) department and the Molecular Imaging Center Antwerp (MICA), focusing on the preclinical evaluation of theranostic radioligands targeting tumor-associated proteases.

Project Overview:

CREANT has expertise in the development of radiolabeled ligands for proteases implicated in human diseases, applicable in PET, SPECT, and targeted radionuclide therapy.
The team has developed novel FAP-targeted radioligands (FAPIs) with improved tumor retention and pharmacokinetics.
This project aims to conjugate these ligands with alpha-emitting radionuclides for precise tumor tissue destruction while sparing healthy organs.
The ultimate goal is to generate preclinical data to support translation into a Phase I clinical trial.

Role and Responsibilities

The successful candidate will:

Design, plan, and execute preclinical experiments in cell and animal cancer models.
Conduct biodistribution, dosimetry, and therapeutic efficacy studies of radiolabeled-FAPI conjugates.
Perform molecular and histological analyses of treatment effects on the tumor microenvironment.
Collaborate with radiochemistry, imaging, and oncology teams within the consortium.
Contribute to scientific publications, reports, and international conference presentations.

Profile / Requirements

Doctoral degree (PhD) in oncology, cancer biology, pharmacology, radiobiology, radiopharmacy, pharmaceutical sciences, or a related field from a non-Belgian institution.
Strong expertise in preclinical animal models (rodents), tumor biology, and therapeutic testing.
Hands-on experience with cell culture and in vitro assays.
Experience in small animal imaging and radiopharmaceuticals is a plus.
Ability to work independently and collaboratively in a multidisciplinary environment.
Excellent scientific writing and communication skills in English.
Research qualities aligned with faculty and university research policies.
Act with attention to quality, integrity, creativity, and cooperation.

What We Offer

Opportunity to contribute to cutting-edge translational cancer research with direct clinical impact.
Collaborative and supportive environment within a multidisciplinary consortium.
Access to state-of-the-art preclinical imaging and radiochemistry facilities.
Opportunities for career development, mentoring, and international networking.
Full-time postdoctoral scholarship for 1 year, extendable up to 3 years after positive evaluation.
Planned start date: March 2, 2026 (or as soon as possible thereafter).
Monthly scholarship amount according to postdoctoral scholarship scales for Contract Research Staff (BAP).
Ecocheques, bicycle allowance, or reimbursement of public transport costs for commuting.
Work location: Laboratories of Radiopharmacy and MICA at campus Drie Eiken, University of Antwerp.

How to Apply

Apply through the University of Antwerp online job application platform.
Include:
- Motivation letter
- Academic CV
- Names and contact details of at least two referees

Applications will be reviewed on a rolling basis until the position is filled.

Questions:

Online application form: jobs@uantwerpen.be
Job content: Prof. Filipe Elvas – filipe.elvas@uantwerpen.be

Diversity and Inclusion

The University of Antwerp has received the European Commission’s HR Excellence in Research Award. We are a sustainable, family-friendly organization that invests in employee growth. We encourage diversity and value an inclusive working environment and equal opportunities, regardless of gender identity, disability, race, ethnicity, religion or belief, sexual orientation, or age.

We encourage people from diverse backgrounds and with diverse characteristics to apply.

If you apply for this position please say you saw it on Academicoxy

Apply

All Jobs